Expiratory muscles and exercise limitation in patients with chronic obstructive pulmonary disease. 1987

J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
Clinique de Pneumologie, Hôpital X.-Arnozan, Centre Hospitalo-Universitaire de Bordeaux, Pessac, France.

The aim of this study was to estimate, in patients with chronic obstructive pulmonary disease (COPD), the maximal strength of the expiratory muscles, its correlation with exercise performance and the effects of a specific physiotherapy. In 38 COPD men, aged 54 +/- 7 years, pulmonary function data, maximal alveolar pressure (Palv, max) developed during forced vital capacity, were measured using a whole-body plethysmograph and the maximal tolerated power (MTP), i.e. the highest power maintained for at least 3 min, was determined by a progressive test on a treadmill. Airway obstruction was severe (FEV1/FVC: 54 +/- 10%), Palv, max was lower than normal (74 +/- 36 vs. 130 +/- 48 hPa in 20 healthy men of the same age; p less than 0.01) and increased with airway resistance values (Raw); mean MTP was low: 115 +/- 30 W and individual values were inversely related to Raw values. Then, two subgroups of 14 patients were chosen at random. One subgroup received an abdominal muscle physiotherapy during 3 weeks. The other subgroup only received usual medical treatment. No modification in any parameter was found in the second subgroup. Specific physiotherapy of abdominal muscles improves significantly both Palv, max (118 +/- 45 hPa) and MTP (171 +/- 38 W; p less than 0.01), without any variation in other respiratory function parameters. We conclude that abdominal muscle weakness is common in COPD patients and can participate in the limitation in exercise performance. Specific physiotherapy increases abdominal muscle strength and seems to improve exercise tolerance by a still unexplained mechanism.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D012132 Respiratory Muscles These include the muscles of the DIAPHRAGM and the INTERCOSTAL MUSCLES. Ventilatory Muscles,Respiratory Muscle,Muscle, Respiratory,Muscle, Ventilatory,Muscles, Respiratory,Muscles, Ventilatory,Ventilatory Muscle
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
April 2006, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
December 1996, American journal of respiratory and critical care medicine,
J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
October 1993, The American review of respiratory disease,
J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
August 1999, American journal of respiratory and critical care medicine,
J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
February 1992, Mayo Clinic proceedings,
J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
June 1994, Clinics in chest medicine,
J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
February 2007, Zhonghua yi xue za zhi,
J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
August 2003, American journal of respiratory and critical care medicine,
J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
August 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace,
J Vergeret, and C Kays, and M L Choukroun, and J J Douvier, and A Taytard, and H Guenard
April 1971, The Journal of clinical investigation,
Copied contents to your clipboard!